Search by Drug Name or NDC

    NDC 11673-0686-80 Headache Relief 250; 250; 65 mg/1; mg/1; mg/1 Details

    Headache Relief 250; 250; 65 mg/1; mg/1; mg/1

    Headache Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TARGET Corporation. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.

    Product Information

    NDC 11673-0686
    Product ID 11673-686_2e6b91c6-6181-4068-b19c-18518061e0ac
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Headache Relief
    Proprietary Name Suffix Extra Strength
    Non-Proprietary Name Acetaminophen, Aspirin, Caffeine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250; 250; 65
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; ASPIRIN; CAFFEINE
    Labeler Name TARGET Corporation
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part343
    Listing Certified Through 2024-12-31

    Package

    NDC 11673-0686-80 (11673068680)

    NDC Package Code 11673-686-80
    Billing NDC 11673068680
    Package 1 BOTTLE, PLASTIC in 1 BOX (11673-686-80) / 80 TABLET in 1 BOTTLE, PLASTIC
    Marketing Start Date 2018-01-31
    NDC Exclude Flag N
    Pricing Information N/A
    << 11673-0686-20 11673-0687-27 >>

    Contents